Recombinant multi-species JUN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine JUN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is the putative transforming gene of avian sarcoma virus 17. It encodes a protein which is highly similar to the viral protein, and which interacts directly with specific target DNA sequences to regulate gene expression. This gene is intronless and is mapped to 1p32-p31, a chromosomal region involved in both translocations and deletions in human malignancies. [provided by RefSeq, Jul 2008]
The Alternative Names of target: AP-1,AP1,Activator protein 1 (AP1),JUN,Jun,Junc,Proto-oncogene c-Jun,Transcription factor AP-1 subunit Jun,Transcription factor Jun,V-jun avian sarcoma virus 17 oncogene homolog,c-Jun,c-jun,cJUN,p39

Target products collectionGo to JUN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T69085-Ag-1/ GM-Tg-hg-T69085-Ag-2 Human JUN protein Human
GM-Tg-rg-T69085-Ag-1/ GM-Tg-rg-T69085-Ag-2 Rat JUN protein Rat
GM-Tg-mg-T69085-Ag-1/ GM-Tg-mg-T69085-Ag-2 Mouse JUN protein Mouse
GM-Tg-cynog-T69085-Ag-1/ GM-Tg-cynog-T69085-Ag-2 Cynomolgus/Rhesus macaque JUN protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T69085-Ag-1/ GM-Tg-felg-T69085-Ag-2 Feline JUN protein Feline
GM-Tg-cang-T69085-Ag-1/ GM-Tg-cang-T69085-Ag-2 Canine JUN protein Canine
GM-Tg-bovg-T69085-Ag-1/ GM-Tg-bovg-T69085-Ag-2 Bovine JUN protein Bovine
GM-Tg-equg-T69085-Ag-1/ GM-Tg-equg-T69085-Ag-2 Equine JUN protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T69085-Ag-1/ GM-Tg-hg-T69085-Ag-2; GM-Tg-rg-T69085-Ag-1/ GM-Tg-rg-T69085-Ag-2;
GM-Tg-mg-T69085-Ag-1/ GM-Tg-mg-T69085-Ag-2; GM-Tg-cynog-T69085-Ag-1/ GM-Tg-cynog-T69085-Ag-2;
GM-Tg-felg-T69085-Ag-1/ GM-Tg-felg-T69085-Ag-2; GM-Tg-cang-T69085-Ag-1/ GM-Tg-cang-T69085-Ag-2;
GM-Tg-bovg-T69085-Ag-1/ GM-Tg-bovg-T69085-Ag-2; GM-Tg-equg-T69085-Ag-1/ GM-Tg-equg-T69085-Ag-2
Products Name JUN protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name JUN
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine JUN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.